- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ANI Pharmaceuticals Inc (ANIP)
ANI Pharmaceuticals Inc stock price live, this page displays NASDAQ ANIP stock exchange data. View the ANIP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ANI Pharmaceuticals Inc real time stock price chart below.
What Is the ANI Pharmaceuticals Inc Stock Price Today?
The ANI Pharmaceuticals Inc stock price today is 63.93.
What Is the Stock Symbol for ANI Pharmaceuticals Inc?
The stock symbol for ANI Pharmaceuticals Inc is ""ANIP.""
What Stock Exchange Does ANI Pharmaceuticals Inc Trade On?
ANI Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is ANI Pharmaceuticals Inc a Good Stock to Buy?
Determining whether ANI Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANIP quote. (ISIN: US00182C1036)
What Is the ANI Pharmaceuticals Inc Stock Price Today?
The ANI Pharmaceuticals Inc stock price today is 63.93.
What Is the Stock Symbol for ANI Pharmaceuticals Inc?
The stock symbol for ANI Pharmaceuticals Inc is ""ANIP.""
What Stock Exchange Does ANI Pharmaceuticals Inc Trade On?
ANI Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is ANI Pharmaceuticals Inc a Good Stock to Buy?
Determining whether ANI Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANIP quote. (ISIN: US00182C1036)
63.93
+0.58(+0.92%)
Closed·
After Hours
62.95-0.98(-1.53%)
·
Fair Value
An estimate of a ANI Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.68
64.38
52 wk Range
52.50
77.00
ANIP Scorecard
Full Analysis
Net income is expected to grow this year
ANIP is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a ANI Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.6864.38
52 wk Range
52.5077.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANIP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a ANI Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
81.38
Upside
+27.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
ANI Pharmaceuticals Inc Company Profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals Inc Earnings Call Summary for Q1/2025
- ANI Pharmaceuticals reports Q1 2025 EPS of $1.70, beating $1.34 forecast; revenue reaches $197.1M, up 43% YoY
- Stock surges 7.65% in premarket trading; company maintains 'GREAT' financial health score of 3.16/5
- Full-year 2025 revenue guidance raised to $768-$793M; adjusted non-GAAP EBITDA expected at $195-$205M
- CEO highlights strong U.S. manufacturing capabilities; over 90% of revenues from domestically produced goods
- Potential challenges include Medicare access for ILUVIEN, sales force turnover, and macroeconomic pressures
Last Updated: 09/05/2025, 14:14
Read Full TranscriptCompare ANIP to Peers and Sector
Metrics to compare | ANIP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANIPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −57.0x | −2.7x | −0.5x | |
PEG Ratio | 0.33 | 0.00 | 0.00 | |
Price/Book | 3.1x | 0.0x | 2.6x | |
Price / LTM Sales | 1.9x | 0.7x | 3.3x | |
Upside (Analyst Target) | 32.2% | 67.1% | 45.1% | |
Fair Value Upside | Unlock | 2.0% | 7.4% | Unlock |
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 81.38
(+27.29% Upside)
Earnings
Latest Release
May 09, 2025
EPS / Forecast
1.70 / 1.34
Revenue / Forecast
197.10M / 179.21M
People Also Watch
FAQ
What Stock Exchange Does ANI Pharma Trade On?
ANI Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for ANI Pharma?
The stock symbol for ANI Pharma is "ANIP."
What Is the ANI Pharma Market Cap?
As of today, ANI Pharma market cap is 1.28B.
What Is ANI Pharma's Earnings Per Share (TTM)?
The ANI Pharma EPS (TTM) is -1.15.
When Is the Next ANI Pharma Earnings Date?
ANI Pharma will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is ANIP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has ANI Pharma Stock Split?
ANI Pharma has split 3 times.
How Many Employees Does ANI Pharma Have?
ANI Pharma has 897 employees.
What is the current trading status of ANI Pharma (ANIP)?
As of 04 Aug 2025, ANI Pharma (ANIP) is trading at a price of 63.93, with a previous close of 63.93. The stock has fluctuated within a day range of 62.68 to 64.38, while its 52-week range spans from 52.50 to 77.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.